{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:38:15Z","timestamp":1712795895149},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,10]]},"DOI":"10.7759\/cureus.57950","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T09:46:07Z","timestamp":1712742367000},"source":"Crossref","is-referenced-by-count":0,"title":["Acquired Thrombotic Thrombocytopenic Thrombocytopenia Presenting As Urinary Tract Infection and Perianal Abscess: A Case Review"],"prefix":"10.7759","author":[{"given":"Oluwaremilekun","family":"Tolu-Akinnawo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikelola","family":"Oyeleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikenna","family":"Nnamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39494","article-title":"A rare case of thrombotic thrombocytopenic purpura (TTP) with concurrent renal cell carcinoma: diagnostic and therapeutic challenges","volume":"15","author":"Bhandari A","year":"2023","unstructured":"Bhandari A, Pokhrel B, Oli PR, Le Q, Basnet B, Freitag EC, Nayani A. A rare case of thrombotic thrombocytopenic purpura (TTP) with concurrent renal cell carcinoma: diagnostic and therapeutic challenges. Cureus. 2023, 15:e39494. 10.7759\/cureus.39494","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8477","article-title":"A rare case of acquired thrombotic thrombocytopenic purpura triggered by acute pancreatitis","author":"Sravanthi MV","year":"2020","unstructured":"Sravanthi MV, Suma Kumaran S, Sharma N, Bojanapally P. A rare case of acquired thrombotic thrombocytopenic purpura triggered by acute pancreatitis. Cureus. 2020, 12:e8477. Accessed: February 7, 2023, from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32642381\/.. 10.7759\/cureus.8477"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.911679","article-title":"A rare case of thrombotic thrombocytopenic purpura caused by pancreatitis and clopidogrel","author":"Rawala MS","year":"2018","unstructured":"Rawala MS, Naqvi ST, Khan MY, El Toukhy A. A rare case of thrombotic thrombocytopenic purpura caused by pancreatitis and clopidogrel. Am J Case Rep. 2018, 19:1288-91. Accessed: February 7, 2023, from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30374015\/.. 10.12659\/AJCR.911679"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i12.3808","article-title":"Acute pancreatitis-induced thrombotic thrombocytopenic purpura: a case report","volume":"10","author":"Wang CH","year":"2022","unstructured":"Wang CH, Jin HF, Liu WG, Guo Y, Liu Z. Acute pancreatitis-induced thrombotic thrombocytopenic purpura: a case report. World J Clin Cases. 2022, 10:3808-13. 10.12998\/wjcc.v10.i12.3808","journal-title":"World J Clin Cases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/342327","article-title":"Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis","volume":"35","author":"Riegert-Johnson DL","year":"2002","unstructured":"Riegert-Johnson DL, Sandhu N, Rajkumar SV, Patel R. Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis. Clin Infect Dis. 2002, 35:636-7. 10.1086\/342327","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.12478","article-title":"Urinary tract infection associated with thrombotic microangiopathy","volume":"6","author":"Ardalan M","year":"2014","unstructured":"Ardalan M. Urinary tract infection associated with thrombotic microangiopathy. Nephrourol Mon. 2014, 6:e12478. 10.5812\/numonthly.12478","journal-title":"Nephrourol Mon"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPGM0SC6KOTCAN","article-title":"Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection?","volume":"135","author":"Park YA","year":"2011","unstructured":"Park YA, Schultz EF, Hay SN, Brecher ME. Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection?. Am J Clin Pathol. 2011, 135:85-8. 10.1309\/AJCPGM0SC6KOTCAN","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07458.x","article-title":"Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry","volume":"144","author":"McDonald V","year":"2009","unstructured":"McDonald V, Laffan M, Benjamin S, Bevan D, Machin S, Scully MA. Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. Br J Haematol. 2009, 144:430-3. 10.1111\/j.1365-2141.2008.07458.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(85)90180-x","article-title":"Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen","author":"Asada Y","year":"1985","unstructured":"Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K. Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res. 1985, 38:469-79. Accessed: February 7, 2023, from: https:\/\/pubmed.ncbi.nlm.nih.gov\/2861671\/. 10.1016\/0049-3848(85)90180-x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.8.1890.1890","article-title":"Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic","volume":"80","author":"Thompson CE","year":"1992","unstructured":"Thompson CE, Damon LE, Ries CA, et al.. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992, 80:1890-5. 10.1182\/blood.V80.8.1890.1890","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-1101(1998)13:1<16:: aid-jca3>3.0.co;2-c","article-title":"Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura","volume":"13","author":"Cohen JA","year":"1998","unstructured":"Cohen JA, Brecher ME, Bandarenko N, et al.. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apher. 1998, 13:16-9. 10.1002\/(sici)1098-1101(1998)13:1&lt;16:: aid-jca3&gt;3.0.co;2-c","journal-title":"J Clin Apher"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9705034","article-title":"Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection","volume":"157","author":"Kayal S","year":"1998","unstructured":"Kayal S, Ja\u00efs JP, Aguini N, Chaudi\u00e8re J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med. 1998, 157:776-84. 10.1164\/ajrccm.157.3.9705034","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-010","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo A","year":"2004","unstructured":"Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood. 2004, 104:100-6. 10.1182\/blood-2004-01-010","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock GA","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991, 325:393-7. 10.1056\/NEJM199108083250604","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully M","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, et al.. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012, 158:323-35. 10.1111\/j.1365-2141.2012.09167.x","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.014","article-title":"A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family","volume":"36","author":"Apte SS","year":"2004","unstructured":"Apte SS. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol. 2004, 36:981-5. 10.1016\/j.biocel.2004.01.014","journal-title":"Int J Biochem Cell Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.413.413","article-title":"Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura","volume":"50","author":"Bukowski RM","year":"1977","unstructured":"Bukowski RM, King JW, Hewlett JS, et al.. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood. 1977, 50:413-7. 10.1182\/blood.V50.3.413.413","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1087153","article-title":"Recent therapeutic advances in thrombotic thrombocytopenic purpura","volume":"5","author":"Byrnes JJ","year":"1979","unstructured":"Byrnes JJ, Lian EC. Recent therapeutic advances in thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 1979, 5:199-215. 10.1055\/s-0028-1087153","journal-title":"Semin Thromb Hemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2021.12.2.8","article-title":"Caplacizumab for acute thrombotic thrombocytopenic purpura","volume":"12","author":"Katsivalis KV","year":"2021","unstructured":"Katsivalis KV, Thomas J. Caplacizumab for acute thrombotic thrombocytopenic purpura. J Adv Pract Oncol. 2021, 12:211-5. 10.6004\/jadpro.2021.12.2.8","journal-title":"J Adv Pract Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04836.x","article-title":"Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature","volume":"124","author":"Yomtovian R","year":"2004","unstructured":"Yomtovian R, Niklinski W, Silver B, Sarode R, Tsai HM. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. Br J Haematol. 2004, 124:787-95. 10.1111\/j.1365-2141.2004.04836.x","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0522","article-title":"Rituximab therapy for refractory thrombotic thrombocytopenic purpura","volume":"28","author":"Gutterman LA","year":"2002","unstructured":"Gutterman LA, Kloster B, Tsai HM. Rituximab therapy for refractory thrombotic thrombocytopenic purpura. Blood Cells Mol Dis. 2002, 28:385-91. 10.1006\/bcmd.2002.0522","journal-title":"Blood Cells Mol Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-0848","article-title":"Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases","volume":"106","author":"Fakhouri F","year":"2005","unstructured":"Fakhouri F, Vernant JP, Veyradier A, et al.. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood. 2005, 106:1932-7. 10.1182\/blood-2005-03-0848","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06448.x","article-title":"Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13","volume":"136","author":"Scully M","year":"2007","unstructured":"Scully M, Cohen H, Cavenagh J, et al.. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol. 2007, 136:451-61. 10.1111\/j.1365-2141.2006.06448.x","journal-title":"Br J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20764","article-title":"Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor","volume":"82","author":"Schleinitz N","year":"2007","unstructured":"Schleinitz N, Ebbo M, Mazodier K, et al.. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor. Am J Hematol. 2007, 82:417-8. 10.1002\/ajh.20764","journal-title":"Am J Hematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely SK","year":"2003","unstructured":"Vesely SK, George JN, L\u00e4mmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003, 102:60-8. 10.1182\/blood-2003-01-0193","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.00626.x","article-title":"Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients","volume":"44","author":"Raife T","year":"2004","unstructured":"Raife T, Atkinson B, Montgomery R, Vesely S, Friedman K. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion. 2004, 44:146-50. 10.1111\/j.1537-2995.2004.00626.x","journal-title":"Transfusion"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng XL","year":"2004","unstructured":"Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood. 2004, 103:4043-9. 10.1182\/blood-2003-11-4035","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000133622.03370.07","article-title":"Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement","volume":"83","author":"Coppo P","year":"2004","unstructured":"Coppo P, Bengoufa D, Veyradier A, et al.. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore). 2004, 83:233-44. 10.1097\/01.md.0000133622.03370.07","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/237915-acquired-thrombotic-thrombocytopenic-thrombocytopenia-presenting-as-urinary-tract-infection-and-perianal-abscess-a-case-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T09:46:10Z","timestamp":1712742370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/237915-acquired-thrombotic-thrombocytopenic-thrombocytopenia-presenting-as-urinary-tract-infection-and-perianal-abscess-a-case-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.57950","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,10]]}}}